According to this, severe mutations that result in complete loss of NaV1.1 function lead to Dravet syndrome, whereas mutations that only partially reduce NaV1.1 activity cause milder phenotypic variants. The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.